A citation-based method for searching scientific literature

Edoardo Spina, Jose de Leon. J Neural Transm (Vienna) 2015
Times Cited: 90







List of co-cited articles
667 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Pharmacogenetics: from bench to byte--an update of guidelines.
J J Swen, M Nijenhuis, A de Boer, L Grandia, A H Maitland-van der Zee, H Mulder, G A P J M Rongen, R H N van Schaik, T Schalekamp, D J Touw,[...]. Clin Pharmacol Ther 2011
617
20

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.
J K Hicks, J R Bishop, K Sangkuhl, D J Müller, Y Ji, S G Leckband, J S Leeder, R L Graham, D L Chiulli, A LLerena,[...]. Clin Pharmacol Ther 2015
474
20

AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011.
C Hiemke, P Baumann, N Bergemann, A Conca, O Dietmaier, K Egberts, M Fric, M Gerlach, C Greiner, G Gründer,[...]. Pharmacopsychiatry 2011
521
16

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.
C Hiemke, N Bergemann, H W Clement, A Conca, J Deckert, K Domschke, G Eckermann, K Egberts, M Gerlach, C Greiner,[...]. Pharmacopsychiatry 2018
382
16

Pharmacogenomics in psychiatry: from therapeutic drug monitoring to genomic medicine.
S Crettol, J de Leon, C Hiemke, C B Eap. Clin Pharmacol Ther 2014
38
36


Serious respiratory infections can increase clozapine levels and contribute to side effects: a case report.
Jose de Leon, Francisco J Diaz. Prog Neuropsychopharmacol Biol Psychiatry 2003
74
18


Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.
J K Hicks, J J Swen, C F Thorn, K Sangkuhl, E D Kharasch, V L Ellingrod, T C Skaar, D J Müller, A Gaedigk, J C Stingl. Clin Pharmacol Ther 2013
282
14

The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype.
A Gaedigk, S D Simon, R E Pearce, L D Bradford, M J Kennedy, J S Leeder. Clin Pharmacol Ther 2008
515
14


Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.
J Kirchheiner, K Nickchen, M Bauer, M-L Wong, J Licinio, I Roots, J Brockmöller. Mol Psychiatry 2004
497
11

Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test.
L Bertilsson, J A Carrillo, M L Dahl, A Llerena, C Alm, U Bondesson, L Lindström, I Rodriguez de la Rubia, S Ramos, J Benitez. Br J Clin Pharmacol 1994
245
11

Clozapine dosages and plasma drug concentrations.
W H Chang, S K Lin, H Y Lane, W H Hu, M W Jann, H N Lin. J Formos Med Assoc 1997
58
17

Applications of CYP450 testing in the clinical setting.
C F Samer, K Ing Lorenzini, V Rollason, Y Daali, J A Desmeules. Mol Diagn Ther 2013
191
10

Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
Magnus Ingelman-Sundberg, Sarah C Sim, Alvin Gomez, Cristina Rodriguez-Antona. Pharmacol Ther 2007
770
10


Prediction of CYP2D6 phenotype from genotype across world populations.
Andrea Gaedigk, Katrin Sangkuhl, Michelle Whirl-Carrillo, Teri Klein, J Steven Leeder. Genet Med 2017
249
10

Clozapine Metabolism in East Asians and Caucasians: A Pilot Exploration of the Prevalence of Poor Metabolizers and a Systematic Review.
Can-Jun Ruan, Yan-Nan Zang, Chuan-Yue Wang, Yu-Hang Cheng, Chuan Sun, Edoardo Spina, Jose de Leon. J Clin Psychopharmacol 2019
29
31

Can valproic acid be an inducer of clozapine metabolism?
F J Diaz, C B Eap, N Ansermot, S Crettol, E Spina, J de Leon. Pharmacopsychiatry 2014
35
22

The dosing of atypical antipsychotics.
Jose de Leon, Scott C Armstrong, Kelly L Cozza. Psychosomatics 2005
85
9


DNA microarray technology in the clinical environment: the AmpliChip CYP450 test for CYP2D6 and CYP2C19 genotyping.
Jose de Leon, Margaret T Susce, Maria Johnson, Mike Hardin, Lorraine Maw, Alison Shao, Antonette C P Allen, Francis A Chiafari, Grantland Hillman, D Michele Nikoloff. CNS Spectr 2009
66
12


The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation.
Jose de Leon, Margaret T Susce, Run-Mei Pan, Maureen Fairchild, Walter H Koch, Peter J Wedlund. J Clin Psychiatry 2005
226
8

Guidelines for the use of clozapine in individuals with developmental disabilities.
Mohamed Sabaawi, Nirbhay N Singh, Jose de Leon. Res Dev Disabil 2006
21
38

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.
Stefan Leucht, Andrea Cipriani, Loukia Spineli, Dimitris Mavridis, Deniz Orey, Franziska Richter, Myrto Samara, Corrado Barbui, Rolf R Engel, John R Geddes,[...]. Lancet 2013
8


Clinical evaluation and plasma clozapine concentrations in Chinese patients with schizophrenia.
S A Chong, C H Tan, Y M Khoo, H S Lee, K E Wong, F Ngui, M Winslow. Ther Drug Monit 1997
47
17

Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia.
Yi-lang Tang, Peixian Mao, Feng-Min Li, Wenbiao Li, Qi Chen, Feng Jiang, Zhuo-ji Cai, Philip B Mitchell. Br J Clin Pharmacol 2007
50
16

Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans.
Roza Ghotbi, Magnus Christensen, Hyung-Keun Roh, Magnus Ingelman-Sundberg, Eleni Aklillu, Leif Bertilsson. Eur J Clin Pharmacol 2007
183
8

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.
J K Hicks, K Sangkuhl, J J Swen, V L Ellingrod, D J Müller, K Shimoda, J R Bishop, E D Kharasch, T C Skaar, A Gaedigk,[...]. Clin Pharmacol Ther 2017
251
8


An inter-ethnic comparison study of clozapine dosage, clinical response and plasma levels.
Chee H Ng, Siow-Ann Chong, Tim Lambert, Agnes Fan, L Peter Hackett, Rathi Mahendran, Mythily Subramaniam, Isaac Schweitzer. Int Clin Psychopharmacol 2005
57
14




Cytochrome P450 2D6 phenoconversion is common in patients being treated for depression: implications for personalized medicine.
Sheldon H Preskorn, Cecelia P Kane, Kasia Lobello, Alice I Nichols, Rana Fayyad, Gina Buckley, Kristen Focht, Christine J Guico-Pabia. J Clin Psychiatry 2013
76
9

Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia.
Anto P Rajkumar, Balasubramanian Poonkuzhali, Anju Kuruvilla, Molly Jacob, Kuruthukulangara S Jacob. Int Clin Psychopharmacol 2013
49
14

ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine.
Eveline Jaquenoud Sirot, Branka Knezevic, Gina Perla Morena, Sabine Harenberg, Beatrice Oneda, Séverine Crettol, Nicolas Ansermot, Pierre Baumann, Chin B Eap. J Clin Psychopharmacol 2009
93
7



Interactions between antiepileptics and second-generation antipsychotics.
Jose de Leon, Vincenza Santoro, Concetta D'Arrigo, Edoardo Spina. Expert Opin Drug Metab Toxicol 2012
50
12


A pilot study on risperidone metabolism: the role of cytochromes P450 2D6 and 3A.
J A Bork, T Rogers, P J Wedlund, J de Leon. J Clin Psychiatry 1999
116
6

Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy.
Dan Cohen, Jan P A M Bogers, Daniel van Dijk, Bert Bakker, Peter F J Schulte. J Clin Psychiatry 2012
96
6

Addressing phenoconversion: the Achilles' heel of personalized medicine.
Rashmi R Shah, Robert L Smith. Br J Clin Pharmacol 2015
135
6



Extension of a pilot study: impact from the cytochrome P450 2D6 polymorphism on outcome and costs associated with severe mental illness.
W H Chou, F X Yan, J de Leon, J Barnhill, T Rogers, M Cronin, M Pho, V Xiao, T B Ryder, W W Liu,[...]. J Clin Psychopharmacol 2000
169
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.